Correction: Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors
- PMID: 40210241
- PMCID: PMC11987129
- DOI: 10.1136/jitc-2021-003982corr1
Correction: Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors
Erratum for
-
Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors.J Immunother Cancer. 2022 Mar;10(3):e003982. doi: 10.1136/jitc-2021-003982. J Immunother Cancer. 2022. PMID: 35260434 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials